LiteVax BV

Biotech company/R&D

www.litevax.comOphemert, Netherlands
1 profile visit

About

LiteVax BV is a biopharmaceutical company focusing on the development and exploitation of novel human vaccine adjuvant products.

Our lead adjuvant candidate outperforms commercially available alternatives with a higher efficacy without overt toxicity.

We are in the clinical stage of development with a second clinical trial focusing on an improved influenza vaccine for the older population.

Social media

HEALTH SECTOR

Human health

CLINICAL DEVELOPMENT AND TRIALS

Clinical trials

INVESTMENT AND BUSINESS DEVELOPMENT

Business development and partnerships

THERAPEUTIC AREAS

Infectious diseases

RESEARCH AND DEVELOPMENT

Vaccine adjuvants

Representatives

Peter Paul Platenburg

Business Developer

LiteVax BV